Patsy, I've been trying to understand this, and from what I can see, you get .83/share for the current shares, then 1 share of the new co. Hemoxymed will be distributed to each existing Ophidian shareholder. Is this correct? For all intense and purposes, there is no difference, but I don't know what the new cos. stock would be priced at since its share structure is not the same as Ophidians.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.